Serrated adenoma: A clinicopathological, DNA ploidy, and immunohistochemical study

Anticancer Research

Volumn 20, Issue 2 B, 2000, Pages 1141-1147

  Iwabuchi, Masahiro ^a,b   Sasano, Hironobu ^a   Hiwatashi, Nobuo ^b   Masuda, Takayuki ^a   Shimosegawa, Tooru ^b   Toyota, Takayoshi ^b   Nagura, Hiroshi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell proliferation; Colon; Serrated adenoma

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); KI 67 ANTIGEN; PROTEIN P53;

ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; CELL PROLIFERATION; COLON CARCINOGENESIS; COLORECTAL CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INTESTINE POLYP; JAPAN; MAJOR CLINICAL STUDY; MALE; PLOIDY; POLYPECTOMY; PRIORITY JOURNAL; RECTUM CARCINOMA; SERRATED ADENOMA; SIGMOID CARCINOMA;

ADENOMA; CELL DIVISION; COLONIC NEOPLASMS; COLONIC POLYPS; DNA TOPOISOMERASES, TYPE II; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; PLOIDIES; RECTAL NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034009733     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Longaere TA and Fenoglio-Preiser CM: Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol 14: 524-537, 1990.
2. Gerdes J, Lemke H and Baisch H et al: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immnol 133: 1710-1715, 1984.
3. Brown DC and Gatter KC: Monoclonal antibody Ki-67: its use in histopathology. Histopathology 17: 489-503, 1990.
4. Heck MMS, Hittleman WN and Earnshaw WC: Differential diagnosis of DNA topoisomerase I and II during the eukaryotic cell cycle. Proc Natl Acad Sci USA 85: 1086-90, 1988.
5. Yabuki N, Sasano H and Kato K et al: Immunohistochemical study of DNA topoisomerase II in human gastric disorder. Am J Pathol 149: 997-1007, 1996.
6. Baker SJ, Fearon ER and Nigro JM et al: Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244: 217-221, 1989.
7. Rodrigues NR, Rowan A and Smith MEF et al: p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87: 7555-7559, 1990.
8. Itakura Y, Sasano H and Mori S et al: DNA ploidy in human esophageal squamous cell carcinomas as determined by image analysis. Mod Pathol 7: 867-873, 1994.
9. Bosari S, Lee AKC and Wiley BD et al: DNA quantitation by image analysis of paraffin-embedded colorectal adenocarcinomas and its prognosis value. Mod Pathol 5: 324-328, 1992.
10. Konishi F and Morson BC: Pathology of colorectal adenomas: a colonoscopic survey. J Clin Patholol 35: 830-841, 1981
11. Matsumoto T, Mizuno M and Shimizu M et al: Serrated adenoma of the colorectum: colonoscopic and histologic features. Gastrointest Endosc 49: 736-742, 1999.
12. Vogelstein B, Fearon ER and Hamilton SR et al: Genetic alterations during colorectal -tumor development. N Engl J Med 319: 525-532, 1988.
13. Fearon ER and Vogelstein B: A genetic model for colorectal tumorgenesis. Cell 61: 759-767, 1990.
14. Uchida H, Ando H and Maruyama K et al: Genetic alterations of mixed hyperplastic adenomatous polyps in the colon and rectum. Jpn J Cancer Res 89: 299-306, 1998.
15. Ajioka Y, Watanabe H and JR Jass et al: Infrequent K-ras 12 mutaion in serrated adenomas of human colorectum. Gut 42: 680-684, 1998.
16. Hiyama T, Yokozaki H and Shimamoto F et al: Frequent p53 gene mutations in serrated adenomas of the colorectum. J. Pathol 186: 131-139, 1998.
17. Yao T, Kouzuki T and Kajiwara M et al: "Serrated" adenoma of the colorectum, with reference to its gastric differenciation and its malignant potential. J Pathol 187: 511-517, 1999.
18. Kang M, Mitomi H and Sada M et al: Ki-67, p53, bcl-2 expression of serrated adenomas of the colon. Am J Surg Pathol 21: 417-423, 1997.
19. Iino H, Jass JR and Simms LA et al: DNA microsatellite instability in hyperplastic polyps, serrated adenomas and mixed polyps: a mild mutator pathway for colorectal cancer? J Clin Pathol 52: 5-9, 1999.
20. Torlakovic E and Snover DC: Serrated adenomatous polyposis in humans. Gastroenterology 110: 748-755, 1996.
21. Grinnell RS and Lane N: Benign and malignant adenomatous polyps and papillary adenomas of the colon and rectum. An analysis of 1856 tumours in 1335 patients. Int Abstr Surg 106: 519-538, 1958.
22. Enterline HT, Evans GW and Mercado-Lugo R et al: Malignant potential of adenomas of colon and rectum. JAMA 179: 322-330, 1962.
23. Muto T, Bussey HJR and Morson BC: The evolution of the cancer of the colon and rectum. Cancer 36: 2251-2270, 1975.
24. Shinya H and Wolff WI: Morphology, anatomic distribution and cancer potential of colonic polyps. Ann Surg 190: 679-683, 1979.
25. O'brien MJ, Winawer SJ and Zauber AG et al: The National Polyp Study patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 98: 371-379, 1990.
26. Rubio C, Kato Y and Hirota T et al: Histologic classification of endoscopically removed flat colorectal polyps: A multicentric study. Jpn. J. Cancer Res 87: 849-855, 1996.
27. Estrada RG and Spjut HJ: Hyperplastic polyp of the large bowl. Am J Surg Pathol 4: 127-133, 1980.
28. Williams GT, Arthur JF and Bussey HJR et al: Metaplastic polyp and polyposis of the colorectum. Histopathology 4: 155-170, 1980.
29. Franzin G and Novelli P: Adenocarcinoma occurring in a hyperplastic (metaplastic) polyp of the colon. Endoscopy 14: 28-30, 1982.
30. Franzin G, Dina R and Zamboni G et al: Hyperplastic (metaplastic) polyp of the colon. Am J Surg Pathol 8: 687-698, 1984.
31. Jen J, Powell SM and Papadopoulos N et al: Molecular determinants of dysplasia incolorectal lesions. Cancer Res 54: 5523-5526, 1994.
32. Otori K, Oda Y and Sugiyama K et al: High frequency of K-ras mutations in human colorectal hyperplastic polyps. Gut 40: 660-663, 1997.
33. Bardi G, Pandis N and Fenger C et al: Deletion of 1p36 as a primary chromosomal aberration in intestinal tumorgenesis. Cancer Res 53: 1895-1897, 1993.
34. Lothe RA, Anderson SN and Hofstad B et al: Deletion of 1p loci and microsatellite instability in colorectal polyps. Genes, Chromosomes Cancer 14: 182-188, 1995.
35. Konishi M, Kikuchi-Yanoshita R and Tanaka K et al: Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology 111: 307-317, 1996.
36. Jeevaratnam P, Cottier DS and Browett PJ et al: Familial giant hyperplastic polyposis predisposing to colorectal cancer: a new hereditary bowel cancer syndrome. J Pathol 179: 20-25, 1996.
37. Iggo R, Gatter K and Barke KJ et al: Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 335: 675-679, 1990.
38. Marks JR, Davidoff AW and Kerns BJ et al: Overexpression and mutations of p53 in epithelial ovarian cancer. Cancer Res 51: 2979-2984, 1991.
39. Bass IO, Mulder J-WR and Offerhaus JA et al: An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 172: 5-12, 1994.
40. Rubio CA and Rodensjo M: p53 overexpression in flat serrated adenomas and flat tubular adenomas of the colorectal mucosa. J Cancer Res Clin Oncol 121: 571-576, 1995.
41. Bauer TW, Tubbs RR and Edinger MG et al: A prospective comparison of DNA quantitation by image and flow cytometry. Am J Clin Pathol 93: 322-326, 1990.
42. Lee AKC, Dugan J and Hamilton WM et al: Quantitative DNA analysis in breast carcinomas: a comparison between image analysis and flow cytometry. Mod Pathol 4: 178-182, 1991.
43. Danque POV, Chen HB and Patil J et al: Image analysis versus flow cytometry for DNA ploidy quantitation of solid tumors: a comparison of six methods of sample preparation. Mod Pathol 6: 270-275, 1993.
44. Bosari S, Lee AKC and Wiley BD et al. Flowcytometric and image analysis of colorectal adenocarcinomas: a comparative study with clinical correlations. Am J Clin Pathol 99: 187-194, 1993.